Status:
RECRUITING
Molecular Characterization of Genetic Alterations in Pediatric Solid Tumors
Lead Sponsor:
National Council of Scientific and Technical Research, Argentina
Conditions:
Pediatric Solid Tumors
Eligibility:
All Genders
Up to 18 years
Brief Summary
Background: In Argentina, central nervous system (CNS) solid tumors (19%) and non-CNS solid tumors (25%) account for 44% of pediatric tumors. The new World Health organization (WHO) 2016 classificatio...
Eligibility Criteria
Inclusion
- Must have a suspected or known diagnosis of neuroblastoma, rhabdomyosarcoma, Ewing sarcoma family tumors, soft tissue sarcomas and CNS tumors (gliomas and embryonal) based on the initial diagnostic workup and evidence of gross disease amenable to excision. Specimens may be collected at some or all of the following time points: initial biopsy, tumor resection and at time of possible relapse.
- The patient or his/her legal guardian, as appropriate, must provide written informed consent within 30 days of the removal of the first collection of tissue sample for this protocol.
- The patient is being seen at Hospital de Niños R Gutierrez or at a collaborating institution.
- Patients must be less than or equal to 18 years old at the time of enrollment.
Exclusion
- No access to the tumor tissue sample.
- written informed consent is not obtained.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04773808
Start Date
February 1 2021
End Date
February 1 2026
Last Update
February 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maria Victoria Preciado
Buenos Aires, Argentina, 1425